Bimodal modulation of the botulinum neurotoxin protein-conducting channel
- 3 February 2009
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 106 (5), 1330-1335
- https://doi.org/10.1073/pnas.0812839106
Abstract
Clostridium botulinum neurotoxin (BoNT) is the causative agent of botulism, a neuroparalytic disease. We describe here a semisynthetic strategy to identify inhibitors based on toosendanin, a traditional Chinese medicine reported to protect from BoNT intoxication. Using a single molecule assay of BoNT serotypes A and E light chain (LC) translocation through the heavy chain (HC) channel in neurons, we discovered that toosendanin and its tetrahydrofuran analog selectively arrest the LC translocation step of intoxication with subnanomolar potency, and increase the unoccluded HC channel propensity to open with micromolar efficacy. The inhibitory profile on LC translocation is accurately recapitulated in 2 different BoNT intoxication assays, namely the mouse protection and the primary rat spinal cord cell assays. Toosendanin has an unprecedented dual mode of action on the protein-conducting channel acting as a cargo-dependent inhibitor of translocation and as cargo-free channel activator. These results imply that the bimodal modulation by toosendanin depends on the dynamic interactions between channel and cargo, highlighting their tight interplay during the progression of LC transit across endosomes.Keywords
This publication has 41 references indexed in Scilit:
- Glycosylated SV2A and SV2B Mediate the Entry of Botulinum Neurotoxin E into NeuronsMolecular Biology of the Cell, 2008
- Crucial Role of the Disulfide Bridge between Botulinum Neurotoxin Light and Heavy Chains in Protease Translocation across MembranesJournal of Biological Chemistry, 2007
- A neuronal cell‐based botulinum neurotoxin assay for highly sensitive and specific detection of neutralizing serum antibodiesFEBS Letters, 2007
- Single molecule detection of intermediates during botulinum neurotoxin translocation across membranesProceedings of the National Academy of Sciences, 2007
- Biological effects of toosendanin, a triterpenoid extracted from Chinese traditional medicineProgress in Neurobiology, 2007
- Mechanism of Substrate Recognition by Botulinum Neurotoxin Serotype AJournal of Biological Chemistry, 2007
- An in vitro and in vivo disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonistsProceedings of the National Academy of Sciences, 2007
- SV2 Is the Protein Receptor for Botulinum Neurotoxin AScience, 2006
- The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nervesFEBS Letters, 2006
- Structural Analysis of Botulinum Neurotoxin Type E Catalytic Domain and Its Mutant Glu212→Gln Reveals the Pivotal Role of the Glu212 Carboxylate in the Catalytic Pathway,Biochemistry, 2004